Quantcast

Latest Exosome Diagnostics Inc. Stories

2014-01-13 04:20:54

GERMANTOWN, Maryland, and HILDEN, Germany, January 13, 2014 /PRNewswire/ -- - Expanding collaboration to develop FDA-regulated diagnostics based on exosomes to measure gene mutations targeted by new anti-cancer therapies - Non-invasive detection of biomarkers from blood reduces patient risk and advances access to the benefits of personalized medicine - Automated biofluid-based molecular diagnostics have significant potential to...

2009-07-23 08:14:00

Zdechlik was Founding member of the U.S. Clinical Molecular Diagnostic Group NEW YORK, July 23 /PRNewswire-USNewswire/ -- Exosome Diagnostics, Inc., the developer of non-invasive molecular oncology diagnostics to aid in early cancer detection and therapeutic selection, announced today that Greg Zdechlik has been named Chief Operating Officer. As COO, Zdechlik will be responsible for driving diagnostic development, commercial relations, and product introduction including Exosome's new...

2009-06-22 09:00:00

NEW YORK, June 22 /PRNewswire/ -- Exosome Diagnostics, Inc. ("ExosomeDX") and DxS Ltd. ("DxS") today announced that they will collaborate on the development of blood-based companion diagnostics for key cancer gene mutations, such as KRAS, BRAF and EGFR. The collaboration will use DxS' industry leading Scorpions(R) real-time PCR Mutation Test Kits in conjunction with ExosomeDX's xOS(TM) technology which harvests high-quality nucleic acids from blood exosomes. The collaboration will...

2008-09-12 09:00:51

NEW YORK, Sept. 12 /PRNewswire/ -- Exosome Diagnostics, Inc. today announced the appointment of Johan Skog, Ph.D., as director of genetics research. In this role, Dr. Skog will oversee the research program that underlies the company's development of its blood-based diagnostics that can identify cancer-specific genetic mutations. Dr. Skog is the primary discoverer and inventor of Exosome Diagnostics' core technology that has been licensed exclusively to the company by Massachusetts General...

2008-09-08 09:00:52

NEW YORK, Sept. 8 /PRNewswire/ -- Exosome Diagnostics, Inc. today announced the formation of its scientific advisory board with the appointments of Dennis Brown, Ph.D.; Xandra Breakefield, Ph.D.; and Richard L. Edelson, M.D. Dr. Brown serves as director of Massachusetts General Hospital's program in membrane biology. He is also associate chief for research affairs of Massachusetts General Hospital's nephrology division and a professor at Harvard Medical School. He is a renowned expert in...

2008-09-03 09:00:46

NEW YORK, Sept. 3 /PRNewswire/ -- Exosome Diagnostics, Inc. today announced additions to its management team as the company moves forward with development of its blood-based diagnostics that can identify cancer-specific genetic mutations. Wayne D. Comper, Ph.D., D.Sc., has joined Exosome Diagnostics as the chief scientific officer. Dr. Comper has extensive experience both as a biotechnology executive and as a biomedical research scientist. Prior to joining Exosome, he was chief science...


Word of the Day
bellycheer
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".
Related